4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
LifeTech Scientific Corporation (1302) operates in the Medical Devices industry and is headquartered in Shenzhen, China with about 1,245 employees. Its market capitalization is roughly CNY 7 billion. In the fiscal year ended 2025-12-31, 1302 reported CNY 1.4B in revenue and CNY 148M in net income.
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 1.4B | CNY 1.3B | CNY 1.3B | CNY 1.1B | — |
| Gross Profit | CNY 1.0B | CNY 981M | CNY 996M | CNY 874M | — |
| Operating Income (EBIT) | CNY 176M | CNY 181M | CNY 294M | CNY 343M | — |
| Net Income | CNY 148M | CNY 222M | CNY 263M | CNY 325M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 5.0B | CNY 4.9B | CNY 4.7B | CNY 3.7B | — |
| Total Liabilities | CNY 1.5B | CNY 1.4B | CNY 1.4B | CNY 769M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1302 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms